Profile data is unavailable for this security.
About the company
Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.
- Revenue in HKD (TTM)2.56bn
- Net income in HKD428.07m
- Incorporated1998
- Employees2.51k
- LocationJoinn Laboratories China Co LtdA5 Rongjing East StreetEconomic-Technological Development AreaBEIJING 100176ChinaCHN
- Phone+86 1 067869582
- Fax+86 1 067869966
- Websitehttps://www.joinnlabs.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lepu Biopharma Co Ltd | 243.00m | -23.83m | 8.16bn | 429.00 | -- | 8.44 | 104.98 | 33.60 | -0.0144 | -0.0144 | 0.1464 | 0.5828 | 0.0917 | 1.06 | 1.62 | 566,422.20 | -1.23 | -- | -1.91 | -- | 87.45 | -- | -13.45 | -- | 0.7201 | 0.1388 | 0.4549 | -- | 1,347.16 | -- | 96.79 | -- | -- | -- |
| AIM Vaccine Co Ltd | 1.28bn | -1.40bn | 9.06bn | 1.62k | -- | 2.31 | -- | 7.07 | -1.16 | -1.16 | 1.06 | 3.24 | -- | -- | -- | 788,446.10 | -- | -- | -- | -- | 75.88 | -- | -164.24 | -- | 0.7583 | -14.04 | 0.3158 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
| Yichang Hec Changjiang Pharmactcl Co Ltd | 6.79bn | 2.15bn | 9.17bn | 4.62k | 4.27 | 1.07 | 3.78 | 1.35 | 2.44 | 2.44 | 7.71 | 9.72 | 0.5111 | 3.62 | 4.09 | 1,469,770.00 | 15.07 | 8.03 | 24.46 | 11.81 | 79.21 | 79.97 | 29.48 | 20.80 | 1.30 | 11.16 | 0.2475 | 15.81 | 68.08 | 20.18 | 2,501.24 | 16.15 | -11.50 | -- |
| InnoCare Pharma Ltd | 796.36m | -680.69m | 9.29bn | 1.09k | -- | 1.08 | -- | 11.67 | -0.4036 | -0.4036 | 0.4719 | 4.37 | 0.073 | 1.39 | 3.39 | 731,274.60 | -6.38 | -13.41 | -8.08 | -15.36 | 82.61 | 85.99 | -87.42 | -172.16 | 4.13 | -- | 0.1582 | -- | 18.09 | 240.36 | 28.80 | -- | 66.20 | -- |
| Cansino Biologics Inc | 372.21m | -1.60bn | 9.69bn | 1.49k | -- | 0.986 | -- | 26.03 | -6.48 | -6.48 | 1.51 | 23.02 | 0.0332 | 2.37 | 0.4619 | 249,134.40 | -18.93 | -4.27 | -26.69 | -5.60 | -253.78 | -- | -569.97 | -27.72 | 1.86 | -- | 0.3381 | -- | -66.52 | 213.94 | -63.04 | -- | 30.60 | -- |
| Keymed Biosciences Inc | 381.82m | -387.49m | 9.92bn | 897.00 | -- | 3.08 | -- | 25.97 | -1.49 | -1.49 | 1.45 | 11.51 | 0.0906 | 0.7314 | 26.14 | 425,660.60 | -9.16 | -- | -10.05 | -- | 89.59 | -- | -101.04 | -- | 9.18 | -- | 0.123 | -- | 253.87 | -- | -16.63 | -- | -- | -- |
| Luye Pharma Group Ltd | 6.62bn | 574.30m | 10.16bn | 5.27k | 17.60 | 0.7517 | 7.59 | 1.53 | 0.1534 | 0.1534 | 1.78 | 3.59 | 0.247 | 2.42 | 3.60 | 1,256,931.00 | 2.17 | 2.80 | 3.56 | 4.45 | 68.44 | 70.53 | 8.78 | 10.39 | 1.21 | 3.10 | 0.3931 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
| Shanghai Henlius Biotech Inc | 5.82bn | 588.77m | 10.24bn | 3.64k | 17.44 | 4.33 | 10.49 | 1.76 | 1.08 | 1.08 | 10.66 | 4.35 | 0.5731 | 1.95 | 9.10 | 1,599,473.00 | 5.80 | -8.59 | 12.47 | -14.14 | 72.64 | 71.77 | 10.12 | -27.37 | 0.3786 | 6.48 | 0.6512 | -- | 67.82 | 273.51 | 178.53 | -- | 49.14 | -- |
| SciClone Pharmaceuticals (Holdings) Ltd | 3.40bn | 1.21bn | 11.52bn | 1.05k | 9.86 | 3.14 | 8.43 | 3.39 | 1.86 | 1.86 | 5.23 | 5.83 | 0.7585 | 3.56 | 3.83 | 3,240,640.00 | 26.97 | 27.09 | 33.34 | 36.32 | 74.67 | 76.06 | 35.55 | 35.43 | 4.50 | 33.70 | 0.01 | 22.98 | 14.76 | 17.50 | 31.16 | 15.96 | 25.65 | -- |
| Joinn Laboratories China Co Ltd | 2.56bn | 428.07m | 12.09bn | 2.51k | 15.51 | 0.7434 | 21.22 | 4.72 | 0.5708 | 0.5708 | 3.41 | 11.91 | 0.2331 | 1.11 | 7.19 | 1,020,934.00 | 3.84 | 8.92 | 4.59 | 11.01 | 41.21 | 46.67 | 16.48 | 32.00 | 4.11 | -- | 0.0083 | 24.50 | 4.78 | 42.20 | -63.04 | 30.36 | 8.21 | -- |
| SSY Group Ltd | 6.46bn | 1.32bn | 14.04bn | 5.60k | 10.69 | 2.03 | 8.03 | 2.17 | 0.4427 | 0.4427 | 2.17 | 2.33 | 0.5637 | 3.00 | 3.01 | 1,154,109.00 | 11.59 | 10.51 | 15.58 | 14.03 | 56.01 | 58.72 | 20.57 | 18.62 | 1.60 | 29.61 | 0.317 | 38.56 | 0.4505 | 9.10 | 17.44 | 7.66 | 3.94 | 13.56 |
| Zai Lab Ltd | 2.27bn | -2.65bn | 15.08bn | 2.18k | -- | 2.49 | -- | 6.64 | -2.73 | -2.73 | 2.34 | 6.11 | 0.2697 | 2.84 | 5.61 | -- | -31.41 | -37.72 | -36.81 | -42.72 | 62.86 | 64.75 | -116.45 | -282.44 | 4.43 | -- | 0.0596 | -- | 24.03 | 360.03 | 24.51 | -- | -3.45 | -- |
| 3SBio Inc | 8.43bn | 1.67bn | 15.17bn | 5.41k | 9.24 | 0.9859 | 7.32 | 1.80 | 0.6733 | 0.6733 | 3.45 | 6.31 | 0.3426 | 1.58 | 7.01 | 1,557,542.00 | 6.95 | 7.44 | 9.03 | 9.29 | 84.98 | 82.91 | 20.30 | 21.50 | 2.26 | 22.72 | 0.2266 | -- | 13.84 | 11.26 | -19.13 | 3.94 | 8.78 | -- |
| Simcere Pharmaceutical Group Ltd | 7.13bn | 770.72m | 15.27bn | 7.03k | 20.23 | 1.97 | 13.83 | 2.14 | 0.2891 | 0.2891 | 2.73 | 2.98 | 0.6106 | 3.53 | 2.65 | 1,013,966.00 | 6.60 | 10.17 | 8.94 | 15.60 | 75.43 | 78.82 | 10.80 | 17.50 | 1.87 | 0.9742 | 0.1652 | 46.68 | 4.49 | 7.92 | -23.22 | -0.5213 | 23.93 | -- |
Data as of May 24 2024. Currency figures normalised to Joinn Laboratories China Co Ltd's reporting currency: Hong Kong Dollar HKD
32.48%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| APG Asset Management NVas of 31 Aug 2022 | 5.86m | 4.92% |
| Brown Brothers Harriman & Co. (Investment Management)as of 05 Mar 2024 | 5.73m | 4.82% |
| UBS Asset Management (Hong Kong) Ltd.as of 29 Apr 2024 | 5.45m | 4.58% |
| UBS SDIC Fund Management Co., Ltd.as of 30 Jun 2023 | 4.08m | 3.43% |
| The Vanguard Group, Inc.as of 09 May 2024 | 3.90m | 3.28% |
| FIL Investment Management (Singapore) Ltd.as of 06 Mar 2024 | 3.67m | 3.08% |
| FIL Investment Management (Hong Kong) Ltd.as of 06 Mar 2024 | 3.36m | 2.82% |
| abrdn Investment Management Ltd.as of 15 Mar 2024 | 3.31m | 2.78% |
| Abrdn Asia Ltd.as of 15 Mar 2024 | 1.78m | 1.49% |
| BlackRock Advisors (UK) Ltd.as of 24 Apr 2023 | 1.51m | 1.27% |
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
